{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:35:09Z","timestamp":1769607309506,"version":"3.49.0"},"reference-count":64,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:p>Congenital neuromuscular disorders, such as Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and Pompe disease (acid maltase deficiency [AMD]), are candidates for universal newborn screening (NBS). In this article, we discuss the future path of NBS for these disorders with particular emphasis on DMD NBS, because of the likely approval of new gene\u2010modifying treatments, the possible benefits of earlier treatment with corticosteroids, and the recently demonstrated feasibility of a 2\u2010tiered approach to NBS with screening by creatine kinase (CK) levels in dried blood spots followed by mutation detection in those with elevated CK. The cystic fibrosis (CF) NBS program is a successful model for NBS. CF outcomes have consistently improved into adulthood following introduction of CF NBS because considerable resources have been devoted to practices that include: attention to improving laboratory screening, consistent confirmatory testing and immediate referral of all newly diagnosed infants to designated CF care centers that follow established practice guidelines, and ongoing evaluation of CF care centers via a centralized clinical database. Like CF, DMD, SMA, and infantile AMD are inexorably debilitating and require lifetime multidisciplinary clinical management. NBS would address the delays in diagnosis that prevent patients from receiving timely treatments. Standardized care following early diagnosis would reduce disparities in clinical care and outcomes. NBS in these neuromuscular disorders should be implemented, utilizing lessons learned from the past 20 years of CF NBS: standardized protocols for all patients identified by DMD NBS, longitudinal follow\u2010up in multidisciplinary clinics, and coordinated oversight of these clinics. Ann Neurol 2015;77:189\u2013197.<\/jats:p>","DOI":"10.1002\/ana.24316","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T07:47:44Z","timestamp":1416988064000},"page":"189-197","source":"Crossref","is-referenced-by-count":17,"title":["Cystic fibrosis newborn screening: A model for neuromuscular disease screening?"],"prefix":"10.1002","volume":"77","author":[{"given":"Michele A.","family":"Scully","sequence":"first","affiliation":[{"name":"Department of Neurology University of Rochester Medical Center Rochester NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Farrell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics University of Wisconsin School of Medicine and Public Health Madison WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Ciafaloni","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Rochester Medical Center Rochester NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Griggs","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Rochester Medical Center Rochester NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Rochester Medical Center Rochester NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"281","article-title":"Principles and practice of mass screening for disease [in Spanish]","volume":"65","author":"Wilson JM","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318210655d"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.05.017"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000156114"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2013.03.009"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3667"},{"key":"e_1_2_8_8_1","unstructured":"KemperAR ComeauAM GreenNS et al. Evidence report: newborn screening for Pompe disease.2013.http:\/\/www.hrsa.gov\/advisorycommittees\/mchbadvisory\/heritabledisorders\/nominatecondition\/reviews\/pompereport2013.pdf; accessed 9\/1\/2014."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23528"},{"issue":"1","key":"e_1_2_8_10_1","first-page":"CD003725","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur AY","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000148485.00049.B7"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.12.1874"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32833f3046"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33474"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.05.008"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e3282f19f65"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31165"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.02.007"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.6.1492"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1148"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.301"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000084777"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24100"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.54.5.362"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810371004"},{"key":"e_1_2_8_26_1","first-page":"616","article-title":"Application of DNA analysis in a population\u2010screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols","volume":"52","author":"Gregg RG","year":"1993","journal-title":"Am J Hum Genet"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0096"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.04.005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31822623f1"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318282334e"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23272"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2012.691965"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081302"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.11.006"},{"key":"e_1_2_8_36_1","volume-title":"GeneReviews","author":"Moskowitz SM","year":"2001"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90147-1"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328358d533"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1463"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf014"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201309-303OC"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e79"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90825-0"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199109123251104"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.72.5.741"},{"key":"e_1_2_8_46_1","first-page":"495","article-title":"A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma","volume":"37","author":"Fost N","year":"1989","journal-title":"Clin Res"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.1.1"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3089"},{"issue":"13","key":"e_1_2_8_49_1","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse SD","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328353489a"},{"issue":"1","key":"e_1_2_8_51_1","first-page":"CD001402","article-title":"Newborn screening for cystic fibrosis","author":"Southern KW","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2012.05.003"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.09.003"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.04.011"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.1_suppl.1S"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2003.09.022"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.08.011"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1891\/0739-6686.29.303"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.4.699"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-0542(03)00086-1"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.10.012"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrdd.20127"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23810"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.03.057"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33519"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.24316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.24316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T10:08:41Z","timestamp":1696586921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.24316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1002\/ana.24316"],"URL":"https:\/\/doi.org\/10.1002\/ana.24316","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]}}}